Cleared Traditional

K192360 - IntellaMap Orion High Resolution Mappin...

K192360 is the FDA 510(k) clearance for IntellaMap Orion High Resolution Mappin... by Boston Scientific Corporation. It is a Class 2 Cardiovascular device (product code DRF) cleared through the Traditional 510(k) pathway after a 56-day FDA review.

K192360 · Boston Scientific Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2019
Decision
56d
Days
Class 2
Risk

K192360 is an FDA 510(k) clearance for the IntellaMap Orion High Resolution Mapping Catheter. Classified as Catheter, Electrode Recording, Or Probe, Electrode Recording (product code DRF), Class II - Special Controls.

Submitted by Boston Scientific Corporation (St Paul, US). The FDA issued a Cleared decision on October 25, 2019 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1220 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Boston Scientific Corporation devices

Submission Details

510(k) Number K192360 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 30, 2019
Decision Date October 25, 2019
Days to Decision 56 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 125d · This submission: 56d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRF Catheter, Electrode Recording, Or Probe, Electrode Recording
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRF Catheter, Electrode Recording, Or Probe, Electrode Recording

All 96
Devices cleared under the same product code (DRF) and FDA review panel - the closest regulatory comparables to K192360.
Reprocessed Inquiry Steerable Diagnostic EP Catheter
K203261 · Innovative Health, LLC · Mar 2021
LassoStar Circular Mapping Catheter
K193632 · Biosense Webster, Inc. · Jun 2020
Reprocessed Achieve Advance Mapping Diagnostic Electrophysiology Catheter
K191880 · Innovative Health, LLC · Dec 2019
Advisor VL Circular Mapping Catheter, Sensor Enabled
K192037 · Abbott Medical · Sep 2019
Marinr Steerable Intracardiac Electrode Catheter, StableMapr Steerable Intracardiac Electrode Catheter, Torqr Intracardiac Electrode Catheter, Soloist Intracardiac Electrode Catheter
K183547 · Medtronic · Jul 2019
Torqr Intracardiac Electrode Catheter, Soloist Intracardiac Electrode Catheter
K190132 · Medtronic · Jul 2019